
Sean Ekins, PhD, DSc
Founder, Chief Executive Officer

Maggie A.Z. Hupcey, PhD
Chief Operating Officer

Thomas Lane, MS, PhD
Associate Director

Renuka Raman, PhD
Associate Director

Josh Harris, PhD
Associate Director

Aaron Oliver, BA, MBA
Business Development Manager

Amber Carroll, BS
Project Manager

Chris Yogodzinski, MS
Staff Scientist

Meena Hamilton, PhD
Staff Scientist

Patricia Vignaux, PhD
Staff Scientist

Thane Jones, PhD
Staff Scientist

Jason Wong
Staff Scientist

Morgan Barnes, PhD
Postdoctoral Associate

Melanie Tojong, BS
Software Engineer

Alexander Kyu, MS
Software Engineer

Cameron Smith, BS
Software Engineer
Advisory Board
Anthony J. Hickey, PhD, ScD
Scientific Advisor
Joshua G. Pierce, PhD
Scientific Advisor
Robert C. Reynolds, PhD
Scientific Advisor
Nancy S. Connell, PhD
Scientific Advisor
Ethan O. Perlstein, PhD
Scientific Advisor
Aaron McMurtray, MD, PhD
Scientific Advisor
James H. Wikel, BS, MS
Scientific Advisor
Christopher Southan, PhD
Scientific Advisor
Sharon King
Rare Disease Advisor
Andrea Barry, BA, MS
Business Advisory
Message From Our Founder
Since founding Collaborations Pharmaceuticals we have focussed on both software development and a drug discovery. By developing software to help us build our own pipeline it would also have value for others through fee for service work and that would help fund our research.
A key aspect of bringing a therapy to market is finding the initial funds to make this happen. We have a proven track record of obtaining funding through the NIH (we are ranked 12 in the state of NC for 2023 for NIH funding) and DOD. We let our results speak for themselves as it has enabled us currently to bring one treatment to the manufacturing/ IND enabling toxicology stage.
So how can we help you and your company? We provide decades of drug discovery experience and our software can be used to design and score new compounds versus diseases and targets, as well as calculate properties or predict toxicities of interest. We can identify novel molecules or repurpose existing molecules for different diseases. We can help create a pipeline of molecules (or evaluate their properties) for your company so you do not have to. We can also license our software and/ or machine learning models so your scientists can leverage our technologies.
Whether you are a biotech, pharma, animal health, agrochemical, consumer product company or a government organization we can help provide the solution to your business needs.
If you are a company looking to license molecules, a rare disease patient wondering what we have to offer, or want to schedule a one-on-one with us, please get in touch.
Cheers,
Sean Ekins, Ph.D., D.Sc., CEO